Understanding the mechanism and the role of inflammation on TMPRSS6 regulation may ultimately lead to new therapeutic strategies to treat diseases where hepcidin levels are deregulated such as β-thalassemia and anemia of chronic disease. This evidence concerns the gene TMPRSS6 and anemia (phenotype).